In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
OverviewOpzelura is approved by the U.S. Food and Drug Administration (FDA) for the treatment of nonsegmental vitiligo in adults and children ages 12 years and older. Opzelura is also known by its drug name, ruxolitinib.
…
Join